<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:hpo ids='HP_0004308'>Ventricular arrhythmia</z:hpo> is a significant cause of <z:hpo ids='HP_0001699'>sudden death</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Implantable cardioverter-defibrillators (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICDs</z:e>) offer at-risk patients a prophylactic treatment option </plain></SENT>
<SENT sid="2" pm="."><plain>This prophylaxis is largely responsible for growth in utilization of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICDs</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Identification of factors that may impact device-specific quality of life (QOL) is warranted </plain></SENT>
<SENT sid="4" pm="."><plain>The influence of preimplant patient variables on postimplant device-specific QOL is unknown </plain></SENT>
<SENT sid="5" pm="."><plain>The study aimed to determine whether preimplant psychosocial, generic health-related quality of life (HRQOL), personality disposition, or demographic factors predicted early postimplant device-specific QOL </plain></SENT>
<SENT sid="6" pm="."><plain>METHODS: A prospective cohort study design was employed in 70 adults receiving an <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> for primary prevention </plain></SENT>
<SENT sid="7" pm="."><plain>Preimplant, we measured generic HRQOL, personality disposition, depressive symptoms, age, and sex </plain></SENT>
<SENT sid="8" pm="."><plain>The primary outcome was 3-month <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> device-specific QOL as measured by the Florida Patient Acceptance Scale (FPAS) </plain></SENT>
<SENT sid="9" pm="."><plain>We applied hierarchical multivariate regression analysis </plain></SENT>
<SENT sid="10" pm="."><plain>RESULTS: Mean age was 64.8 ± 9.4 years; 12.9% were women </plain></SENT>
<SENT sid="11" pm="."><plain>Most had <z:e sem="disease" ids="C0151744" disease_type="Disease or Syndrome" abbrv="IHD">ischemic heart disease</z:e> (77%) and a <z:hpo ids='HP_0001635'>heart failure</z:hpo> history (54.3%) </plain></SENT>
<SENT sid="12" pm="."><plain>Preimplant prevalence of elevated depressive symptoms was 30% </plain></SENT>
<SENT sid="13" pm="."><plain>Three months post implant, the mean adjusted FPAS score was 76.8 ± 12.98 </plain></SENT>
<SENT sid="14" pm="."><plain>Of the variance in FPAS scores, 37% was explained by the independent variables </plain></SENT>
<SENT sid="15" pm="."><plain>Younger age and poor preimplant mental HRQOL contributed most to lower FPAS scores </plain></SENT>
<SENT sid="16" pm="."><plain>CONCLUSIONS: Patient support and psychosocial interventions should target younger <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ICD</z:e> candidates and those reporting poor preimplant mental HRQOL; these patients may be at risk for poor postimplant device-specific QOL </plain></SENT>
</text></document>